What Can Falsely Elevate BNP Levels?

Dozens of clinical scenarios can push BNP (B-type natriuretic peptide) levels above the thresholds normally used to diagnose heart failure, even when the heart itself is functioning fine. Kidney disease, advancing age, sepsis, certain medications, and even a long bike race can all raise the number on your lab report. Understanding these confounders matters because a misread BNP result can trigger unnecessary imaging, hospital admissions, or medication changes that carry their own risks.

Why BNP Rises in the First Place

BNP is released primarily by heart muscle cells when they are stretched or under pressure. That is why it works as a marker for heart failure, a condition defined by the heart struggling to pump effectively. But anything that stretches heart walls, increases fluid volume, impairs the body’s ability to clear BNP from the bloodstream, or directly stimulates its release from cardiac tissue can produce a high reading without classic heart failure being present. The body clears BNP through a specific receptor and through an enzyme called neprilysin, while its companion marker NT-proBNP is cleared mainly by the kidneys.¹ Any disruption to these clearance pathways tips the balance toward higher circulating levels.

Kidney Disease Is the Biggest Confounder

Impaired kidney function is probably the single most common reason BNP and NT-proBNP climb without new or worsening heart failure. As kidney filtration declines, the body simply cannot remove natriuretic peptides from the blood as quickly, so they accumulate. Studies of patients with chronic kidney disease show that both BNP and NT-proBNP rise steadily as kidney function drops, with BNP increasing by roughly a fifth for every modest step down in filtration rate and NT-proBNP increasing even more steeply.² The effect on NT-proBNP is considerably larger than on BNP itself, because NT-proBNP depends more heavily on the kidneys for clearance.³

This means that if you have moderate-to-severe kidney disease and your doctor orders a BNP or NT-proBNP, the raw number is almost certainly higher than it would be in someone with normal kidneys, even if your heart is identical. Clinicians are supposed to adjust their interpretation for kidney function, but in busy emergency departments this step sometimes gets missed. If your kidney function is known to be reduced, it is worth asking whether the BNP result has been read with that in mind.

Age, Sex, and Body Weight

Getting older raises your baseline BNP even if your heart is perfectly healthy. In population studies, BNP increases with each decade of life, and women tend to have higher levels than men of the same age.⁴ The practical problem is that most labs print a single cutoff on the report without adjusting for age or sex, so a 78-year-old woman with a reading just above the threshold might be flagged as abnormal when her level is actually unremarkable for her demographic. In older patients, the ability of BNP to confidently rule out heart failure is weaker precisely because the baseline is already elevated.⁵

Body weight pulls the number in the opposite direction. People with obesity tend to have lower BNP levels than expected, which can mask actual heart failure. The exact mechanism is debated, but natriuretic peptide receptors on fat tissue likely scavenge some BNP from the blood before it reaches a lab tube. Research has also noted that people of African-American descent tend to have lower natriuretic peptide levels, a pattern that persists even after adjusting for common confounders.⁶ So while this article focuses on false elevations, it is worth knowing that false suppression is a real problem too, and it disproportionately affects certain groups.

Pulmonary Embolism and Right Heart Strain

A blood clot lodged in the lungs can send BNP soaring, because the sudden spike in pulmonary artery pressure forces the right side of the heart to work much harder. In patients with acute pulmonary embolism who developed complications, median BNP was roughly five times higher than in patients whose course was uncomplicated.⁷ Another study found that patients with measurable right ventricular dysfunction after a pulmonary embolism had BNP levels about six times higher than those without it.⁸

This creates a diagnostic trap in emergency medicine. A patient arrives short of breath, BNP comes back high, and the instinct is to treat for heart failure. But the actual problem is a clot in the lungs, which needs anticoagulation rather than diuretics. Conditions like chronic obstructive pulmonary disease with an acute flare, severe pulmonary hypertension, and even acute respiratory distress syndrome can cause the same kind of right-heart strain and BNP elevation. Any time the right ventricle is working against abnormally high resistance, BNP goes up regardless of left ventricular function.

Sepsis and Systemic Inflammation

Severe infection drives BNP levels to impressively high numbers. In one study, patients diagnosed with septic shock had a mean BNP around 850 pg/mL, compared with about 100 pg/mL in healthy controls of the same age.⁹ The mechanism involves a combination of factors: inflammatory molecules directly stimulate BNP release from heart cells, the widespread vasodilation of sepsis increases cardiac workload, and fluid resuscitation stretches the ventricles. The heart may also sustain direct injury from circulating toxins. Because BNP is measured so frequently in emergency departments, and because sepsis also causes shortness of breath, the overlap is a constant source of confusion for clinicians.

Liver Cirrhosis

Advanced liver disease creates a high-output circulatory state where the heart pumps more blood than usual through dilated blood vessels. This chronic volume overload stretches the heart chambers and stimulates BNP release. Research on cirrhotic patients has shown significantly higher BNP levels compared with non-cirrhotic controls, with the elevation tracking closely with disease severity. Patients with complications like ascites, variceal bleeding, and hepatic encephalopathy had even higher levels than cirrhotic patients without those features.¹⁰ An important nuance: some of these patients also develop a real condition called cirrhotic cardiomyopathy, where the heart muscle itself becomes impaired. So the elevated BNP is not always “false” in liver disease. It sometimes reflects genuine cardiac problems caused by the liver disease itself.

Thyroid Dysfunction

An overactive thyroid gland revs up the cardiovascular system, increasing heart rate, stroke volume, and overall cardiac output. Even in patients without structural heart disease, hyperthyroidism can push NT-proBNP levels well above normal. Research has demonstrated that rising free thyroid hormone levels independently predict higher NT-proBNP, and this relationship holds even after accounting for heart rate, suggesting the hormone directly stimulates peptide secretion rather than simply making the heart beat faster.¹¹ Hypothyroidism can also affect levels, though in a less predictable pattern. The clinical takeaway is straightforward: thyroid function should be checked before concluding that an elevated natriuretic peptide means heart failure, especially in a patient with no prior cardiac history.

Anemia and High-Output States

Severe anemia forces the heart to compensate for reduced oxygen-carrying capacity by increasing cardiac output. The resulting volume overload and myocardial stretch trigger BNP release through the same mechanism as actual heart failure. Anemia causes peripheral vasodilation from tissue oxygen deprivation, which drops blood pressure and activates stress hormones, leading to fluid retention and an expanded blood volume that further burdens the heart.¹² The tricky part is that anemia and heart failure frequently coexist in the same patient. When they do, correcting the anemia often brings BNP down noticeably, helping to untangle how much of the elevation was driven by the blood count and how much by the heart.

Medications That Alter BNP Readings

One drug class stands out for its dramatic effect on BNP: sacubitril/valsartan, a widely prescribed heart failure medication. This drug works by blocking neprilysin, the same enzyme that breaks down BNP in the bloodstream. With less breakdown occurring, BNP accumulates even when the drug is helping the heart. In clinical trial data, median BNP rose from about 202 to 235 ng/L in the first two to three months of treatment, and in roughly one in five patients, BNP levels actually doubled.¹³ NT-proBNP, which is not broken down by neprilysin, typically falls on the same drug. This discrepancy is clinically important: if you are on sacubitril/valsartan, your doctor should track NT-proBNP rather than BNP when monitoring your heart failure, because the BNP number will be artificially inflated by the medication itself.

Anthracycline-based chemotherapy drugs, commonly used against breast cancer and lymphoma, can also push BNP upward. These agents are known to be toxic to heart muscle cells, and elevations in BNP may appear even before any measurable drop in pumping function shows up on an echocardiogram. In one study following breast cancer patients after anthracycline treatment, about one in five developed elevated BNP during follow-up despite having no clinical heart failure.¹⁴ Whether this represents early subclinical damage or a transient stress response is debated, but either way, the result is a BNP value that could be misinterpreted outside the oncology context.

Intense Exercise

Endurance athletes and weekend warriors alike can spike their natriuretic peptide levels simply by pushing hard enough. In a study of recreational cyclists completing a competitive marathon-distance ride, NT-proBNP jumped roughly tenfold immediately after the race, from a mean of 28 to 278 ng/L.¹⁵ The levels fell quickly over the next day and were back to normal within a week. Researchers interpret this transient spike as a normal volume-regulation response to prolonged exertion rather than a sign of injury. Still, if you happen to get blood drawn during or right after a hard race, the number can look alarming. This is worth mentioning to your doctor if you are an active person and your BNP comes back unexpectedly high.

Brain Injuries and Neurological Events

A particularly unexpected confounder is acute brain injury. After a severe stroke or an aneurysmal subarachnoid hemorrhage (a type of brain bleed), the sympathetic nervous system can unleash a storm of stress hormones that directly damage heart muscle cells in a pattern sometimes called neurogenic stunned myocardium. BNP rises as a result, and the elevation correlates with the severity of the neurological injury. In subarachnoid hemorrhage patients, elevated BNP has been independently linked to complications like cerebral vasospasm and infarction, and to higher in-hospital mortality.¹⁶ In the ICU, a neurology patient with a high BNP can easily be assumed to have a cardiac problem when the primary issue is in the brain.

Laboratory and Assay Interference

Sometimes the problem is not in the patient at all but in the test tube. BNP immunoassays use antibodies derived from mice, and a small number of people carry human anti-mouse antibodies (known as HAMA) in their blood. These antibodies bridge the assay’s capture and detection antibodies, producing a signal that mimics BNP even when none is present. Case reports have documented HAMA interference producing wildly false BNP readings above 4,000 pg/mL in patients with no cardiac disease whatsoever.¹⁷ The interference can be confirmed by adding purified mouse antibodies to the sample, which neutralize the HAMA and bring the reading back to normal.¹⁸

HAMA interference is rare, but it is most likely in people who have received mouse-derived monoclonal antibody therapies (some older cancer treatments, certain imaging agents) or who have frequent occupational exposure to animals. Clinicians should suspect assay interference when a BNP result is drastically out of proportion to the patient’s clinical picture. Pre-analytical issues can also introduce error. How the blood sample is handled, stored, and transported before it reaches the analyzer affects the final number. Natriuretic peptides can degrade in certain tube types or at room temperature, and contaminated samples can produce spurious results.¹⁹ While degradation usually lowers the result rather than raising it, incorrect sample handling remains a recognized source of unreliable readings in both directions.

Practical Guidance for Patients

If your BNP or NT-proBNP comes back elevated and the clinical picture does not obviously fit heart failure, consider whether any of the following apply to you: kidney disease, recent intense exercise, an overactive thyroid, significant anemia, liver cirrhosis, acute lung problems, severe infection, treatment with sacubitril/valsartan, or recent chemotherapy. Any of these can push the number up independently of heart function. It is entirely reasonable to ask your physician whether one of these alternative explanations might account for the result before moving straight to cardiac workup.

The distinction between BNP and NT-proBNP matters here too. Because they are cleared by different pathways, each is susceptible to different confounders. Kidney disease affects NT-proBNP more dramatically than BNP. Sacubitril/valsartan inflates BNP but often lowers NT-proBNP. In clinical practice, knowing which peptide was measured helps determine which confounders are most plausible. Some labs report one, some report the other, and the cutoff values are different for each, so make sure you and your doctor are comparing the result to the right reference range.

When an Elevation Is Real but Not From Heart Failure

A recurring theme in the research is that many of these “false” elevations are not truly false at all. The heart really is under stress during sepsis, after a pulmonary embolism, or in severe anemia. The BNP is doing exactly what it is supposed to do: signaling that the myocardium is struggling. The misleading part is not the number itself but the assumption that a high BNP always means chronic heart failure requiring diuretics and long-term cardiac management. In acute pulmonary embolism, for instance, an elevated BNP is actually prognostically useful because it identifies patients at higher risk for right heart failure and death. The number is “right” in the sense that it reflects real cardiac strain; it is “wrong” only if interpreted as proof of a primary cardiac diagnosis. Keeping that distinction in mind is what separates a BNP reading that helps from one that misleads.